Primus Pharmaceuticals

Biotech · Private

Thiamine derivative molecules for metabolic and inflammatory disease treatment

primuspharmaceuticals.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
39
12 granted · 27 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1989LIGHT SWITCH BIO, LLC——
1990Harpoon Therapeutics—$220M
1991NEOKERA, LLC——
1992Primus Pharmaceuticals——
1993Acelerox, LLC——
1994ViceBio——
1995SENA RESEARCH, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 12 granted of 39

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.